ABEV Volume Alert - ABEV 6.47 Ambev S.A. $ABEV Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
ABEV Volume Alert - ABEV 6.47 Ambev S.A. $ABEV Hit a high of 6.51 Currently 11:14 Last price 6.47 +0.05 +0.78% With a day low of 6.44 and a current volume of 2,835,699.

ABEV Ambev S.A. Recent Headline News

Ambev Reports 2014 Third Quarter Results Under IFRS
PR Newswire - Fri Oct 31, 1:30AM CDT
Ambev S.A. [BOVESPA: ABEV3; NYSE: ABEV] announces today its results for the 2014 third quarter. The following operating and financial information, unless otherwise indicated, is presented in nominal Reais and prepared according to International Financial Reporting Standards (IFRS), and should be read together with our quarterly financial information for the nine-month period ended September 30, 2014 filed with the CVM and submitted to the SEC.
ABEV: 6.42 (unch)

Leading Brazilian Stocks Mixed After Rousseff Victory
at Investor's Business Daily - Mon Oct 27, 6:00PM CDT
Brazilian President Dilma Rousseff won her battle for re-election Sunday, but investors sent a clear message Monday that she was at risk of losing the country's economic war. Investors sent the country's real to a nine-year low. The benchmark...
PBR: 10.60 (-0.30), ERJ: 36.54 (-1.02), ABEV: 6.42 (unch), VALE: 9.23 (-0.20), EBR: 2.40 (+0.08), CQB: 14.44 (+0.01), BRFS: 25.31 (-0.10), MELI: 136.24 (+1.49)

Brazil Heads To Polls Amid Economic Stagnation
at Investor's Business Daily - Wed Oct 22, 5:22PM CDT
The latest poll in Brazil shows presidential incumbent Dilma Rousseff with a 47%-to-43% lead over challenger Aecio Neves in Sunday's runoff election. Although Rousseff is seen as the candidate of the left and Neves the candidate of the right, many...
PBR: 10.60 (-0.30), ERJ: 36.54 (-1.02), ABEV: 6.42 (unch), BRFS: 25.31 (-0.10), EWZ: 40.90 (-0.08)

Why Ambev S.A. (ABEV) Stock Continues to Rise Today
at The Street - Tue Oct 07, 11:10AM CDT
Shares of Ambev S.A. (ABEV) were up for the second consecutive day Tuesday after Brazil's presidential election on Sunday resulted in a runoff to be held on October 26.
ABEV: 6.42 (unch)

Brazilian Investors See Tight Election As Good Sign
at Investor's Business Daily - Mon Oct 06, 5:47PM CDT
Brazilian markets and stocks rallied Monday after a Sunday vote set up an unexpected, head-to-head runoff in the country's presidential election. Incumbent Dilma Rousseff topped the polls with nearly 42% of the vote. Challenger Marina Silva, a former...
GFA: 1.80 (-0.01), PBR: 10.60 (-0.30), BBD: 14.30 (+0.20), ABEV: 6.42 (unch), GOL: 4.83 (-0.04), ITUB: 14.20 (+0.10)

Why Ambev S.A. ¿(ABEV) Stock Is Up Today
at The Street - Mon Oct 06, 11:13AM CDT
Shares of Ambev S.A. (ABEV) were up in early afternoon trading Monday after Brazil's presidential election on Sunday resulted in a runoff to be held on October 26.
ABEV: 6.42 (unch)

Petrobras, Brazil Stocks Jump On Election Results
at Investor's Business Daily - Mon Oct 06, 10:38AM CDT
Petrobras and other Brazil stocks jumped early Monday as Brazil's leftist president will face a more conservative rival in a runoff election. President Dilma Rousseff received nearly 42% of the vote, but she didn't get enough to win outright and will...
PBR: 10.60 (-0.30), ERJ: 36.54 (-1.02), ABEV: 6.42 (unch), GOL: 4.83 (-0.04)

'Mad Money' Lightning Round: I Want Pepsico Over Coca-Cola
at The Street - Thu Sep 25, 5:00AM CDT
Cramer sees Yelp and Kraft Foods going higher but not Chart Industries.
KO: 42.37 (+0.05), HD: 97.47 (-0.18), ABEV: 6.42 (unch), TAP: 76.37 (-0.81), STZ: 93.51 (-0.05), KRFT: 57.68 (-0.19), YELP: 58.88 (+0.47), GTLS: 45.89 (-1.06), PEP: 96.70 (-0.10)

Jim Cramer's 'Mad Money' Recap: Why You Can't Get Too Negative in This Market
at The Street - Wed Sep 24, 7:24PM CDT
Investors always need to be prepared for when common sense returns to the market, Cramer says.
BIIB: 324.90 (+4.15), RTN: 103.52 (-0.84), DAL: 43.00 (+0.31), WYNN: 178.03 (+0.85), WMT: 79.99 (+1.22), KRFT: 57.68 (-0.19), ACOR: 35.66 (+0.55), PEP: 96.70 (-0.10), LUV: 38.74 (+0.50), NOV: 74.11 (+0.85), PAYX: 47.43 (+0.10), V: 249.63 (-2.80), ETP: 66.54 (+0.53), GDOT: 21.56 (-0.50), CMG: 645.92 (-3.11), COST: 137.22 (-0.49), CFG: 24.00 (+0.03), HAWK: 36.30 (unch), TAL: 43.24 (-0.25), OXY: 88.47 (+0.43), AAPL: 108.99 (-0.02), REGN: 382.02 (+4.18), KO: 42.37 (+0.05), HD: 97.47 (-0.18), KR: 58.31 (+0.51), HCN: 70.95 (+0.33), TAP: 76.37 (-0.81), STZ: 93.51 (-0.05), DIS: 89.26 (-0.74), MO: 49.94 (+0.07), BA: 124.70 (+0.25), ALK: 55.88 (+0.74), GTLS: 45.89 (-1.06), CELG: 107.55 (+1.10), WWAV: 35.80 (-1.13), BBBY: 69.43 (-0.45), GILD: 107.43 (+0.98), ABEV: 6.42 (unch), AIG: 54.09 (+0.06), YELP: 58.88 (+0.47), SHW: 235.99 (-0.05), NVS: 92.36 (+0.60)

Why Taking the PepsiCo-Anheuser-Busch InBev Relationship a Big Step Further Makes Sense
Jake Mann, The Motley Fool - Motley Fool - Sat Aug 30, 1:08PM CDT
BookFinch , Flickr. Ongoing consolidation in the global beer marketplace means another acquisition is likely a question of when, not if.  Over the past decade, beer companies have participated in a bevy of big-time mergers and acquisitions,...
BUD: 109.19 (+0.85), GS: 191.50 (+0.79), ABEV: 6.42 (unch), TAP: 76.37 (-0.81), YUM: 73.49 (+0.63), PEP: 96.70 (-0.10)

Six Alcohol Industry Stocks to Consider for Your Stock Portfolio
at The Street - Thu Aug 21, 11:51AM CDT
Here are six alcohol stocks and companies that you can consider investing in.
ABEV: 6.42 (unch), TAP: 76.37 (-0.81), STZ: 93.51 (-0.05), SAM: 262.83 (+3.93), CCU: 20.82 (-0.27), BF.B: 93.87 (+0.28)

Why Ambev (ABEV) Stock Is a 'Buy' at TheStreet
at The Street - Fri Aug 08, 2:39PM CDT
TheStreet Ratings team reiterates its 'buy' rating for Ambev (ABEV) with a ratings score of B-.
ABEV: 6.42 (unch)

Ambev Reports 2014 Second Quarter Results Under IFRS
PR Newswire - Thu Jul 31, 1:01AM CDT
Ambev S.A. [BOVESPA: ABEV3; NYSE: ABEV] announces today its results for the 2014 second quarter. The following operating and financial information, unless otherwise indicated, is presented in nominal Reais and prepared according to International Financial Reporting Standards (IFRS), and should be read together with our quarterly financial information for the six-month period ended June 30, 2014 filed with the CVM and submitted to the SEC.
ABEV: 6.42 (unch)

Why Ambev (ABEV) Stock Is Still a 'Buy'
at The Street - Wed Jun 25, 3:21PM CDT
TheStreet Ratings team reiterates its 'buy' rating for Ambev (ABEV) with a ratings score of B+.
ABEV: 6.42 (unch)

Jim Cramer's Stop Trading: There's a Beer Deal Coming
at The Street - Fri Jun 20, 11:26AM CDT
TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, said there appears to be a deal brewing in the beer industry.
ABEV: 6.42 (unch), TAP: 76.37 (-0.81), STZ: 93.51 (-0.05), MO: 49.94 (+0.07)

Brazil's 5 Biggest U.S. Stocks Are No World Beaters
at Investor's Business Daily - Thu Jun 12, 1:15PM CDT
As the World Cup begins today, Brazil's soccer team is favored to win the month-long global tournament, but the host country's economy gets a yellow card as its big companies such as Petroleo Brasiliero (PBR) -- Petrobras -- deal with red tape and an...
BUD: 109.19 (+0.85), PBR: 10.60 (-0.30), BCA: 19.61 (+0.03), BBD: 14.30 (+0.20), ABEV: 6.42 (unch), VALE: 9.23 (-0.20), ITUB: 14.20 (+0.10)

Hunting for a Smoother Ride in Rough Emerging Markets
at The Street - Wed Apr 02, 9:01AM CDT
In the choppy emerging markets, some winning managers use distinctive strategies to limit losses.
ABEV: 6.42 (unch), CL: 68.21 (+0.16)

Can You Profit From World Cup Woes?
Calla Hummel, The Motley Fool - Motley Fool - Thu Mar 06, 5:31PM CST
For the last two weeks, Brazil's main cities have been wracked by Carnival preparations and growing protests against the World Cup, which is set to start in June. The public disapproval adds uncertainty to an already fraught preparation : Six...
PBR: 10.60 (-0.30), ABEV: 6.42 (unch), EWZ: 40.90 (-0.08)

Goals Galore for FIFA World Cup Sponsors - Analyst Blog
Supriyo Bose - Zacks Investment Research - Thu Mar 06, 8:57AM CST
The FIFA World Cup 2014 will provide marketers with a dream opportunity to push their brands as four billion fans are expected to tune in on television and a multitude of digital and social media channels.
KO: 42.37 (+0.05), YGE: 2.79 (+0.02), BUD: 109.19 (+0.85), AMX: 23.52 (-0.63), FB: 74.87 (-0.73), SNE: 20.54 (+0.92), GOOG: 547.69 (+6.68), JNJ: 108.53 (+0.33), V: 249.63 (-2.80), ABEV: 6.42 (unch), MCD: 95.06 (-0.04), BP: 42.05 (-0.01), PG: 89.11 (-0.02), ITUB: 14.20 (+0.10)

Brazil Lowers GDP Growth Estimate. How Will It Impact These ADRs?
Louie Grint, The Motley Fool - Motley Fool - Wed Feb 26, 6:15PM CST
The turmoil in the emerging markets is not over yet. Brazil has decided to cut $18.5 billion from this year's budget in addition to lowering its GDP growth estimate to 2.5% from the 3.8% expected previously. Why is this happening? Well,...
ABEV: 6.42 (unch), ITUB: 14.20 (+0.10), CBD: 41.21 (+0.81)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Morgan Stanley Projects Strong Upswing for Consumer Finance

Updated Category News Views 259

Morgan Stanley's Positive Outlook for Consumer Finance Stocks Morgan Stanley has recently made an uplifting adjustment to its outlook on consumer finance stocks, now branding them as "attractive." This decision stems from robust fundamentals and an improved regulatory environment, setting an optimistic tone for the sector. Key Drivers of Change The primary catalysts...

Continue Reading
Significant Board Restructuring at O2Gold Inc. Announced

Updated Category News Views 71

O2Gold Board Announces Key Changes O2Gold Inc. (NEX: OTGO.H), a dedicated mineral exploration company, has recently undergone a significant change in its board structure. The company has announced that Roger Lemaitre has resigned from his position as a director. This decision marks a pivotal moment for O2Gold as it continues to navigate its exploration initiatives....

Continue Reading
Taylor Morrison Launches Holiday Initiative to Support Homeowners

Updated Category News Views 265

Help for Homeowners During the Holidays In a time when financial strain can be prominent, especially during the holidays, Taylor Morrison (NYSE: TMHC) is stepping up to lend a hand. The renowned homebuilder has introduced an initiative designed to support homeowners facing the threat of foreclosure. With the holiday season often heightening financial challenges, the...

Continue Reading
flatexDEGIRO Moves Ahead After Ending BaFin Oversight

Updated Category News Views 188

flatexDEGIRO Ends Special Commissioner Mandate FRANKFURT - flatexDEGIRO AG, a prominent German financial services provider, has officially announced the conclusion of the special commissioner mandate set by the Federal Financial Supervisory Authority (BaFin). This change will take effect on a specified date in the future. The company has made significant strides in...

Continue Reading
Investigating Alvotech's Regulatory Challenges After Stock Drop

Updated Category News Views 125

Alvotech Faces Scrutiny over Manufacturing Issues National shareholder rights firm Hagens Berman is currently analyzing Alvotech (NASDAQ: ALVO) regarding potential misrepresentations in their disclosures tied to manufacturing operations and the regulatory status of their primary biosimilar candidate, AVT05. Impact of FDA's Complete Response Letter The investigation stems...

Continue Reading